L'Institut de NeuroPhysiopathologie (INP) est un centre d'excellence pour la formation et la recherche qui allie la recherche fondamentale et translationnelle pour étudier l'organisation, la fonction et l'interaction des cellules neurales, les bases moléculaires et cellulaires des principales maladies du cerveau, et développer des stratégies de thérapies cellulaires et moléculaires innovantes.
La PFNT (Plateforme NeuroTimone) est un ensemble cohérent d'outils d'exploration en neurobiologie permettant des investigations aux échelles moléculaires, cellulaires et intégrées.
Maud Gratuze a reçu le pris Joël Ménard 2024 à Paris le 5 décembre. Les Prix Joël Ménard sont destinés à récompenser des médecins et/ou scientifiques âgés de moins de 40 ans menant des travaux de recherche sur la maladie d’Alzheimer ou les maladies apparentées.
Ces prix seront attribués en reconnaissance d’un ensemble de travaux, d’une contribution particulière ou d’une constance dans l’effort de recherche.
https://www.fondation-alzheimer.org/la-recherche/prix-joel-menard/maud-g...
Chiara and Maud had the chance to participate to the FENS Winterschool in Obergurgle 🇦🇹 on ‘Protein aggregation in Neurodegenerative disorders’. From insights of the human brain, organoids, non-human primate and cell models to the molecular mechanisms of tau, alpha-Synuclein, TDP43 and Amyloid aggregation.
Alexandre Astier is starting his thesis on the theme : Molecular characterisation of primary and recurrent low-grade gliomas
Christophe (Team 7), Ivan (Team 6), Emmanuel (Team 8) and Sarah (Team 4) participated in NeuroMAP Day, the first event that brought together researchers, clinicians, engineers, and students alongside patient associations focused on brain and nervous system disorders. During the event organized by NeuroMarseille, they presented the research being conducted in their respective labs to the general public, making scientific dissemination more accessible to a broader audience. Thank you very much for your participation!
Sarah Moyon 's and Emmanuel Nivet 's teams are glad to be present at the 27th Meeting of the French Glial Cell Club.
Congrats to Marine Dos Santos, Nicolas Vermeersch, Naz Şerifoğlu, Ivan Fernandez Bessone and Raphaël Touron for their poster presentation !
We are pleased to announce that our team has obtained a FRM "2024 prematuration" grant for a project in collaboration with BBB team and Vect-Horus.
The funding will start 1st of November for one year and will allow us to pursue our scientific research on MT5-MMP and its role in Alzheimer disease using in this particular project vectorised mimetic peptides as a potential therapeutical approach.
Maud Gratuze (SynapTau team) has been invited to the SNE 2024 in Nice to give a presentation titled "Unveiling the Brain's Chubby Secrets: Disrupted Cholesterol and Lipid Metabolism in Alzheimer's Disease" at a symposium on Alzheimer's disease.
A new article from the GlioME Team has just been published in Cell Death and Disease: SMAC mimetic drives microglia phenotype and glioblastoma immune microenvironment.
Maud Gratuze a reçu le pris Joël Ménard 2024 à Paris le 5 décembre. Les Prix Joël Ménard sont destinés à récompenser des médecins et/ou scientifiques âgés de moins de 40 ans menant des travaux de recherche sur la maladie d’Alzheimer ou les maladies apparentées.
Ces prix seront attribués en reconnaissance d’un ensemble de travaux, d’une contribution particulière ou d’une constance dans l’effort de recherche.
Chiara and Maud had the chance to participate to the FENS Winterschool in Obergurgle 🇦🇹 on ‘Protein aggregation in Neurodegenerative disorders’. From insights of the human brain, organoids, non-human primate and cell models to the molecular mechanisms of tau, alpha-Synuclein, TDP43 and Amyloid aggregation.
A 3-year full-time doctoral position is available at the Institute of Neuropathophysiology (INP) (https://inp.univ-amu.fr), CNRS/Aix-Marseille University. This position is funded by the Vaincre Alzheimer foundation, and the successful candidate is expected to start at the beginning of 2025.
Alexandre Astier is starting his thesis on the theme : Molecular characterisation of primary and recurrent low-grade gliomas
Christophe (Team 7), Ivan (Team 6), Emmanuel (Team 8) and Sarah (Team 4) participated in NeuroMAP Day, the first event that brought together researchers, clinicians, engineers, and students alongside patient associations focused on brain and nervous system disorders. During the event organized by NeuroMarseille, they presented the research being conducted in their respective labs to the general public, making scientific dissemination more accessible to a broader audience.
Sarah Moyon 's and Emmanuel Nivet 's teams are glad to be present at the 27th Meeting of the French Glial Cell Club.
Congrats to Marine Dos Santos, Nicolas Vermeersch, Naz Şerifoğlu, Ivan Fernandez Bessone and Raphaël Touron for their poster presentation !
We are pleased to announce that our team has obtained a FRM "2024 prematuration" grant for a project in collaboration with BBB team and Vect-Horus.
The funding will start 1st of November for one year and will allow us to pursue our scientific research on MT5-MMP and its role in Alzheimer disease using in this particular project vectorised mimetic peptides as a potential therapeutical approach.
Maud Gratuze (SynapTau team) has been invited to the SNE 2024 in Nice to give a presentation titled "Unveiling the Brain's Chubby Secrets: Disrupted Cholesterol and Lipid Metabolism in Alzheimer's Disease" at a symposium on Alzheimer's disease.
A new article from the GlioME Team has just been published in Cell Death and Disease: SMAC mimetic drives microglia phenotype and glioblastoma immune microenvironment.
Aix Marseille Université | All rights reserved - Legal notice
